NADAC acquisition cost data for ALOSETRON HCL 1 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
| 00054029613 | $8.58 | 2022-01-19 | Rx |
Generic: Alosetron HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $14.8M | 11,152 | 2,291 | $22.16 |
| 2020 | $14.3M | 11,171 | 2,158 | $21.01 |
| 2021 | $13.7M | 11,569 | 2,283 | $19.95 |
| 2022 | $13.5M | 10,982 | 2,173 | $19.87 |
| 2023 | $12.7M | 11,107 | 2,223 | $17.81 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.